Abstract
Artennisinin resistance containment in Myanmar was initiated in 2011 after artemisinin-resistant Plasmodium falciparum malaria was reported. Molecular evidence suggests that asymptomatic malaria infections harboring drug resistance genes are present among residents of the Myanmar artemisinin resistance containment zone. This evidence supports efforts to eliminate these hidden infections.
Original language | English |
---|---|
Pages (from-to) | 517-520 |
Number of pages | 4 |
Journal | Emerging Infectious Diseases |
Volume | 23 |
Issue number | 3 |
Early online date | 17 Feb 2017 |
DOIs | |
Publication status | Published - Mar 2017 |
Keywords
- Plasmodium-vivax
- PVMDR1
- Chloroquine
- Falciparum
- Thailand